Empresa AntriaBio Inc OTC Bulletin Board
Acciones
US0372301095
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
22/05 | Principales ganancias antes de la comercialización | MT |
21/05 | Transcript : Rezolute, Inc. - Special Call |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 66 | 26/07/10 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 26/07/10 |
Daron Evans
DFI | Director of Finance/CFO | 50 | 24/01 |
Chief Tech/Sci/R&D Officer | - | 20/05/21 | |
Brain Roberts
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/17 |
Chris Milks
PRN | Corporate Officer/Principal | - | - |
Erin O’Boyle
PRN | Corporate Officer/Principal | - | 01/03/19 |
Michael Deperro
PRN | Corporate Officer/Principal | - | 01/01/16 |
Susan Stewart
LAW | General Counsel | 64 | 01/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 26/07/10 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 10/02/19 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 20/11/19 |
Philippe Fauchet
BRD | Director/Board Member | 65 | 10/09/20 |
Nerissa Kreher
BRD | Director/Board Member | 51 | 02/03/21 |
Director/Board Member | 59 | 02/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 40 135 147 | 31 953 951 ( 79,62 %) | 0 | 79,62 % |
Información de la empresa
Rezolute, Inc.
275 Shoreline Drive Suite 500
94065, Redwood City
+650 206 4507
http://www.rezolutebio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+12,30 % | 118 mil M | |
+12,15 % | 106 mil M | |
-8,14 % | 23,4 mil M | |
-1,69 % | 21,78 mil M | |
-10,60 % | 18,09 mil M | |
-41,25 % | 16,72 mil M | |
-15,33 % | 15,97 mil M | |
+5,80 % | 14,03 mil M | |
+28,03 % | 11,67 mil M |
- Bolsa de valores
- Acciones
- Acción RZLT
- Acción
- Empresa AntriaBio Inc